<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Enzymatic measures of hepatic cholestasis (alkaline phosphatase, 5'-nucleotidase, gamma-glutamyl transpeptidase)</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Enzymatic measures of hepatic cholestasis (alkaline phosphatase, 5'-nucleotidase, gamma-glutamyl transpeptidase)</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Enzymatic measures of hepatic cholestasis (alkaline phosphatase, 5'-nucleotidase, gamma-glutamyl transpeptidase)</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Lawrence S Friedman, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sanjiv Chopra, MD, MACP</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Shilpa Grover, MD, MPH, AGAF</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 01, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The liver contains thousands of enzymes, some of which are also present in serum in very low concentrations [<a href="#rid1">1-3</a>]. Elevation of serum enzyme tests can be grouped into two categories:</p><p class="bulletIndent1"><span class="glyph">●</span>Enzymes that reflect generalized damage to hepatocytes</p><p class="bulletIndent1"><span class="glyph">●</span>Enzymes that reflect cholestasis</p><p></p><p>This topic review will discuss the serum tests that reflect cholestasis. The other categories of liver tests and enzymes that reflect generalized damage to hepatocytes and the evaluation of the patient with abnormal liver tests are discussed separately. (See  <a class="medical medical_review" href="/d/html/3573.html" rel="external">"Overview of liver biochemical tests"</a> and  <a class="medical medical_review" href="/d/html/3576.html" rel="external">"Approach to the patient with abnormal liver biochemical and function tests", section on 'Elevated alkaline phosphatase'</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">ALKALINE PHOSPHATASE</span></p><p class="headingAnchor" id="H1754390126"><span class="h2">Physiologic function</span><span class="headingEndMark"> — </span>Alkaline phosphatase refers to a group of enzymes that catalyze the hydrolysis of a large number of organic phosphate esters at an alkaline pH optimum. Zinc is an important cofactor. Although alkaline phosphatase is found in many locations throughout the body, its precise function is not known [<a href="#rid4">4</a>]. It appears to have an active role in down-regulating the secretory activities of the intrahepatic biliary epithelium and hydrolyzing phosphate esters to generate inorganic phosphate for uptake by various tissues [<a href="#rid5">5,6</a>]. Intestinal alkaline phosphatase detoxifies lipopolysaccharide and promotes commensal bacterial colonization of the intestine, tight junction integrity, and barrier function, and its absence is associated with increased intestinal inflammation, dysbiosis, bacterial translocation, and systemic inflammation [<a href="#rid7">7,8</a>]. Genetic mutations of the intestinal alkaline phosphatase gene are thought to contribute to some forms of chronic inflammatory diseases [<a href="#rid8">8</a>]. In bone, the enzyme is involved with calcification. At other sites, it may participate in transport processes.</p><p>At least three separate genes code for the different alkaline phosphatases that exist in multiple isoenzyme forms [<a href="#rid9">9,10</a>]. Although these alkaline phosphatase isoenzymes catalyze the same reactions, they have different physicochemical properties, which are conferred by carbohydrate and lipid side chains added during posttranslational modification [<a href="#rid4">4,10</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Most of the alkaline phosphatase isoenzymes of clinical interest are derived from the liver, bone, first trimester placenta, and kidneys, and are coded for by one gene. They are called tissue nonspecific alkaline phosphatase since they have the same immunologic properties and amino acid sequence. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A second alkaline phosphatase gene codes for third trimester placental and intestinal alkaline phosphatase [<a href="#rid9">9</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The third gene codes for a second type of intestinal alkaline phosphatase.</p><p></p><p class="headingAnchor" id="H857773066"><span class="h2">Sources</span><span class="headingEndMark"> — </span>Alkaline phosphatase activity in serum is derived primarily from three sources: liver (more than 80 percent), bone, and, in some patients, the intestinal tract [<a href="#rid4">4,11</a>]. The intestinal contribution (about 10 to 20 percent) is of importance primarily in people with blood groups O and B who are secretors of the ABH red blood cell antigen [<a href="#rid12">12</a>]; it is enhanced by consumption of a fatty meal [<a href="#rid13">13,14</a>].</p><p>Circulating alkaline phosphatase appears to behave like other serum proteins [<a href="#rid15">15</a>]. Its half-life is seven days, and its clearance from serum is independent of the functional capacity of the liver or the patency of the bile ducts [<a href="#rid15">15</a>]. Sites of degradation of alkaline phosphatase are unknown.</p><p class="headingAnchor" id="H4"><span class="h2">Measurement</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Assay</strong> — The most widely used procedure for determination of serum alkaline phosphatase activity involves measuring the release of p-nitrophenol or phosphate from p-nitrophenylphosphate under specified conditions. The results are expressed in international units (IU/L), which is the activity of alkaline phosphatase that releases 1 mmol of chromogen or inorganic phosphate per minute. Other colorimetric and fluorescent strategies for determining alkaline phosphatase activity and kinetics have been developed [<a href="#rid16">16,17</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fractionating serum alkaline</strong> <strong>phosphatase</strong> — Fractionating serum alkaline phosphatase to identify the source of the elevated isoenzyme is helpful if an elevated serum alkaline phosphatase is the only abnormal finding in an apparently healthy person or if the degree of elevation is higher than expected in the clinical setting. In one series of 317 patients evaluated for an increased serum alkaline phosphatase level, the source of elevation was the liver and bone in 80 and 18 percent, respectively [<a href="#rid18">18</a>]. The remaining patients had either a mixed or an intestinal source.</p><p></p><p class="bulletIndent1">Alkaline phosphatase isoenzymes can be determined using a variety of techniques. However, these methods are not widely available, the most practical approach is to measure other enzymes whose elevation reflects liver disease. These include 5’-nucleotidase and gamma-glutamyl transpeptidase. (See <a class="local">'5'-Nucleotidase'</a> below and <a class="local">'Gamma-glutamyl transpeptidase'</a> below.)</p><p></p><p>Methods to assess isoenzymes of alkaline phosphatase include:</p><p class="bulletIndent2"><span class="glyph">•</span>Separation using polyacrylamide gel slabs – This is the most reliable method and produces clear-cut separations of the liver, bone, intestinal, and placental isoenzymes. However, this method is not always available. Electrophoresis on cellulose acetate, with the addition of heat inactivation, may accomplish the same purpose [<a href="#rid19">19</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Evaluating susceptibility to inactivation by heat – This method is based upon the observation that alkaline phosphatases from individual tissues differ in their susceptibility to inactivation by heat or 2 mol urea [<a href="#rid20">20</a>]. Placental alkaline phosphatase and an isoenzyme found in certain cancers, the Regan isoenzyme, are fully heat-stable after exposure to a temperature of 56°C for 15 minutes [<a href="#rid21">21</a>]. Thus, the finding of an elevated serum alkaline phosphatase concentration in a patient in whom all the excess activity is in a heat-stable fraction strongly suggests that the placenta or a tumor is the source of the elevated enzyme in serum. Unfortunately, in unselected patients, this method has many limitations and is not recommended.</p><p></p><p class="headingAnchor" id="H5"><span class="h2">Clinical interpretation</span></p><p class="headingAnchor" id="H2448488580"><span class="h3">Normal range</span><span class="headingEndMark"> — </span>Normal serum values of alkaline phosphatase vary based upon demographic and clinical circumstances.</p><p class="bulletIndent1"><span class="glyph">●</span>Patients older than 60 have somewhat higher values (up to 1.5 times normal) than younger adults [<a href="#rid22">22,23</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In adults 15 to 50 years of age, mean serum alkaline phosphatase activity is somewhat higher in males than in females [<a href="#rid24">24</a>]. In comparison, in individuals over age 60, the enzyme activity of females equals or exceeds that of males [<a href="#rid22">22</a>]. The alkaline phosphatase is usually derived from the liver in older males and from bone in postmenopausal females [<a href="#rid22">22</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In children, serum alkaline phosphatase activity is considerably elevated in both sexes, correlates well with the rate of bone growth, and appears to be accounted for by the influx of enzyme from osteoid tissue [<a href="#rid24">24,25</a>]. Serum alkaline phosphatase in normal adolescent males may reach mean values three times greater than in normal adults without implying the presence of hepatobiliary disease  (<a class="graphic graphic_figure graphicRef56695" href="/d/graphic/56695.html" rel="external">figure 1</a>) [<a href="#rid24">24,26-28</a>]. Infants and young children occasionally display marked transient elevation of serum alkaline phosphatase activity in the absence of detectable liver or bone disease. (See  <a class="medical medical_review" href="/d/html/5946.html" rel="external">"Transient hyperphosphatasemia of infancy and early childhood"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Enzyme activity in serum may double late in normal pregnancy, primarily because of an influx from the placenta [<a href="#rid29">29</a>]; in rare cases, higher values have been observed [<a href="#rid30">30</a>].</p><p></p><p class="headingAnchor" id="H1057980804"><span class="h3">Elevation in alkaline phosphatase</span><span class="headingEndMark"> — </span>Increased serum alkaline phosphatase is derived from tissues whose metabolism is either functionally disturbed (the obstructed liver) or greatly stimulated (placenta in the third trimester of pregnancy and bone in growing children). However, an elevation in the alkaline phosphatase concentration is a relatively common finding and does not always indicate the presence of hepatobiliary disease. Rarely, an elevated alkaline phosphatase level is seen because of the presence of macro-alkaline phosphatase. Macro-alkaline phosphatase is rare and occurs due to the formation of complexes of alkaline phosphatase with immunoglobulins (usually IgG), which have reduced renal clearance compared with unbound alkaline phosphatase [<a href="#rid31">31</a>]. The clinical significance of these complexes is uncertain. Macro-alkaline phosphatase should be suspected when all other causes of isolated elevations in alkaline phosphatase have been excluded. </p><p>The evaluation of a patient with elevated alkaline phosphatase is discussed in detail separately  (<a class="graphic graphic_table graphicRef99099" href="/d/graphic/99099.html" rel="external">table 1</a> and <a class="graphic graphic_algorithm graphicRef78223" href="/d/graphic/78223.html" rel="external">algorithm 1</a>). (See  <a class="medical medical_review" href="/d/html/3576.html" rel="external">"Approach to the patient with abnormal liver biochemical and function tests", section on 'Evaluation of elevated alkaline phosphatase'</a>.)</p><p class="headingAnchor" id="H1407570555"><span class="h4">Non-hepatic alkaline phosphatase</span><span class="headingEndMark"> — </span>The bone is the most likely source of isolated plasma alkaline phosphatase that is not of liver origin (in nonpregnant patients). An elevated bone alkaline phosphatase is indicative of high bone turnover, which may be caused by several disorders including healing fractures, osteomalacia, hyperparathyroidism, hyperthyroidism, Paget disease of bone, osteogenic sarcoma, and bone metastases. (See  <a class="medical medical_review" href="/d/html/2047.html" rel="external">"Bone physiology and biochemical markers of bone turnover", section on 'Markers of bone turnover'</a> and  <a class="medical medical_review" href="/d/html/5601.html" rel="external">"Clinical manifestations and diagnosis of Paget disease of bone", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/d/html/2040.html" rel="external">"Clinical manifestations, diagnosis, and treatment of osteomalacia in adults", section on 'Diagnostic and etiologic evaluation'</a>.)</p><p>Intestinal alkaline phosphatase has multiple biological functions [<a href="#rid6">6,32</a>]. Elevated levels of intestinal alkaline phosphatase are usually of no clinical significance. They are most often found postprandially after a fatty meal and tend to run in families, suggesting that there may be a genetic basis [<a href="#rid33">33</a>]. Because elevation is nonspecific, it should not prompt evaluation for a particular intestinal disorder. Normalization of the level while fasting can provide reassurance that its origin is intestinal.</p><p class="headingAnchor" id="H2428607446"><span class="h4">Hepatic alkaline phosphatase</span><span class="headingEndMark"> — </span>The major value of the serum alkaline phosphatase in the diagnosis of liver disorders is in the recognition of cholestatic disease [<a href="#rid34">34</a>]. Increased serum alkaline phosphatase in hepatobiliary disease is due to regurgitation of hepatic alkaline phosphatase back into serum by the damaged liver rather than a failure to excrete the alkaline phosphatase made in bone, the intestines, and the liver. The data supporting this theory include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Only hepatic alkaline phosphatase is found in the serum of patients with liver disease, particularly cholestasis [<a href="#rid18">18</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The clearance rates of infused placental alkaline phosphatase are the same in patients with bile duct obstruction and healthy controls [<a href="#rid15">15</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In experimental bile duct obstruction in rats, the entire increase in serum alkaline phosphatase activity is due to the leakage of hepatic alkaline phosphatase into serum [<a href="#rid35">35</a>]. The increased serum activity is paralleled by a striking elevation in hepatic alkaline phosphatase activity and is not accounted for by biliary retention of alkaline phosphatase.</p><p></p><p>Thus, the elevation in serum alkaline phosphatase in hepatobiliary disease results from increased de novo synthesis in the liver followed by release into the circulation [<a href="#rid36">36</a>]. Retained bile acids appear to play a central role in this process; they induce the synthesis of the enzyme and may cause it to leak into the circulation, perhaps by disruption of hepatic organelles and solubilization of phosphatase bound to such membranes [<a href="#rid37">37</a>].</p><p>The precise manner in which the alkaline phosphatase reaches the circulation is unclear. In some patients with cholestasis, small vesicles that contain many basolateral (sinusoidal) membrane enzymes still bound to these membranes, including alkaline phosphatase, have been found in serum [<a href="#rid38">38</a>].</p><p class="headingAnchor" id="H6"><span class="h5">Increase alkaline phosphatase and liver tests</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Marked elevation</strong> — Approximately 75 percent of patients with prolonged cholestasis have serum alkaline phosphatase values increased to four times the upper limit of normal or more. Elevations of this magnitude can occur in a variety of diseases associated with extrahepatic or intrahepatic obstruction  (<a class="graphic graphic_table graphicRef99099" href="/d/graphic/99099.html" rel="external">table 1</a>), and the extent of the elevation does not distinguish between the two [<a href="#rid39">39</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Obstructive jaundice due to cancer.</p><p class="bulletIndent2"><span class="glyph">•</span>Bile duct stones.</p><p class="bulletIndent2"><span class="glyph">•</span>Sclerosing cholangitis (primary or secondary).</p><p class="bulletIndent2"><span class="glyph">•</span>Bile duct stricture.</p><p class="bulletIndent2"><span class="glyph">•</span>Drug and toxins associated with cholestasis.</p><p class="bulletIndent2"><span class="glyph">•</span>Primary biliary cholangitis.</p><p class="bulletIndent2"><span class="glyph">•</span>Liver allograft rejection.</p><p class="bulletIndent2"><span class="glyph">•</span>Ischemic and infectious (eg, coronavirus disease [COVID]) cholangiopathy [<a href="#rid40">40</a>]. </p><p class="bulletIndent2"><span class="glyph">•</span>Infectious hepatobiliary diseases seen in patients with AIDS (eg, cytomegalovirus or microsporidiosis) and in patients with tuberculosis with hepatic involvement.</p><p class="bulletIndent2"><span class="glyph">•</span>Infiltrative liver disease (eg, sarcoidosis, tuberculosis, metastatic malignancy, amyloidosis).</p><p class="bulletIndent2"><span class="glyph">•</span>Familial cholestatic syndromes.</p><p class="bulletIndent2"><span class="glyph">•</span>Alcohol-associated hepatitis (rarely) [<a href="#rid41">41</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Moderate elevation</strong> — Lesser increases in alkaline phosphates activity, up to four times the upper limit of normal, are nonspecific and occur in all types of liver disease, including viral hepatitis, chronic hepatitis, cirrhosis, infiltrative diseases of the liver, and congestive heart failure  (<a class="graphic graphic_table graphicRef99099" href="/d/graphic/99099.html" rel="external">table 1</a>) [<a href="#rid3">3,14,39,42,43</a>]. Elevations in hepatic alkaline phosphatase of this magnitude can also occur in disorders that do not directly involve the liver, such as Hodgkin lymphoma, myeloid metaplasia, intra-abdominal infections, and osteomyelitis [<a href="#rid18">18</a>].</p><p></p><p class="bulletIndent1">A two- to four-fold elevation in serum alkaline phosphatase levels has been described in several members of a family who had no evidence of bone or liver disease [<a href="#rid44">44</a>]. The elevation appeared to be transmitted as an autosomal dominant trait, but the site of the excess alkaline phosphatase could not be determined.</p><p></p><p class="headingAnchor" id="H8"><span class="h5">Isolated elevation</span><span class="headingEndMark"> — </span>Isolated elevations of hepatic alkaline phosphatase can occur in a number of circumstances including:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hepatobiliary causes</strong>  </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Partial bile duct obstruction due to gallstones or tumor. The mechanism is unknown but probably represents local areas of bile duct obstruction with induced synthesis of hepatic alkaline phosphatase and leakage of the alkaline phosphatase into the serum.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Early in the course of some cholestatic liver diseases such as primary sclerosing cholangitis, primary biliary cholangitis, and immunoglobulin G4 (IgG4)-associated cholangitis.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Infiltrative liver diseases such as amyloidosis, sarcoidosis, hepatic abscesses, tuberculosis, and metastatic carcinoma.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Ischemic cholangiopathy.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Extrahepatic diseases</strong> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Nonmalignant causes</strong> – Peritonitis, diabetes mellitus, subacute thyroiditis, uncomplicated gastric ulcer, and sepsis. The increase in alkaline phosphatase in these disorders is related to hepatic dysfunction despite the absence of overt liver disease [<a href="#rid45">45</a>]. Vitamin D deficiency has been associated with an isolated elevation of the alkaline phosphatase level [<a href="#rid1">1</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Malignancy</strong> – Myelofibrosis and extrahepatic tumors, including osteosarcomas; lung, gastric, head and neck, renal cell, ovarian, and uterine cancers; and Hodgkin lymphoma, that secrete alkaline phosphatase (often a form known as the Regan isoenzyme) or cause leakage of hepatic alkaline phosphatase into serum by an unknown mechanism [<a href="#rid18">18,46</a>]. Renal cell carcinoma may also be complicated by non-metastatic cholestatic hepatitis, sometimes termed Stauffer's syndrome [<a href="#rid47">47</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other causes</strong> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Transient hyperphosphatemia of infancy and childhood </strong>– Infants and young children occasionally display marked transient elevation of serum alkaline phosphatase activity in the absence of detectable liver or bone disease. The hyperphosphatasemia typically includes elevations in both bone and liver isoenzymes and appears to be caused by delayed clearance of the enzyme. The clinical presentation and evaluation of an infant or child with this finding is discussed separately. (See  <a class="medical medical_review" href="/d/html/5946.html" rel="external">"Transient hyperphosphatasemia of infancy and early childhood"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Medications </strong>– <a class="drug drug_general" data-topicid="9769" href="/d/drug information/9769.html" rel="external">Phenytoin</a> can cause mild-to-moderate elevations in gamma-glutamyl transpeptidase (GGT), which is indicative of hepatic enzyme induction rather than liver injury. </p><p></p><p class="headingAnchor" id="H9"><span class="h3">Subnormal values</span><span class="headingEndMark"> — </span>Extremely low serum alkaline phosphatase concentrations can be seen in patients with acute liver failure due to Wilson disease complicated by hemolysis [<a href="#rid48">48,49</a>]. (See  <a class="medical medical_review" href="/d/html/83837.html" rel="external">"Wilson disease: Clinical manifestations, diagnosis, and natural history"</a>.)</p><p>Low values can also occur in patients with hypothyroidism, pernicious anemia, zinc deficiency, hypomagnesemia, malnutrition, certain drugs (eg, oral contraceptives), congenital hypophosphatemia, and certain types of progressive familial intrahepatic cholestasis in children.</p><p class="headingAnchor" id="H10"><span class="h1">5'-NUCLEOTIDASE</span></p><p class="headingAnchor" id="H4036817143"><span class="h2">Source</span><span class="headingEndMark"> — </span>5'-nucleotidase is found in the liver, intestine, brain, heart, blood vessels, and endocrine pancreas but it is only released into serum by hepatobiliary tissue [<a href="#rid50">50</a>]. Although its physiologic function is unknown, 5'-nucleotidase specifically catalyzes hydrolysis of nucleotides such as adenosine 5'-phosphate and inosine 5'-phosphate in which the phosphate is attached to the 5 position of the pentose moiety.</p><p>Similar to alkaline phosphatase, 5'-nucleotidase has a subcellular location in hepatocytes [<a href="#rid51">51</a>]. It is bound to bile canalicular and sinusoidal membranes and must be solubilized, perhaps via the detergent action of bile acids, to gain access to the circulation [<a href="#rid52">52</a>]. In experimental bile duct obstruction in rats, bile acid concentrations rapidly reach levels sufficient to disrupt plasma membranes and solubilize the enzyme [<a href="#rid53">53</a>]. The same phenomenon may occur in hepatobiliary disorders in which there is any degree of cholestasis [<a href="#rid51">51</a>].</p><p class="headingAnchor" id="H11"><span class="h2">Measurement</span><span class="headingEndMark"> — </span>Serum 5'-nucleotidase activity is most commonly assayed by measuring the release of inorganic phosphate using 5'-phosphate as a substrate [<a href="#rid54">54</a>]. Serum 5'-nucleotidase concentration is not clearly influenced by sex or race [<a href="#rid55">55,56</a>]. Values are substantially lower in children than in adults, rise gradually in adolescence, and reach a plateau after age 50 [<a href="#rid57">57</a>]. The normal range is 2 to 17 IU/L.</p><p class="headingAnchor" id="H12"><span class="h2">Clinical application</span><span class="headingEndMark"> — </span>The major value of the 5'-nucleotidase assay is its specificity for hepatobiliary disease. Conflicting data have been reported for serum 5'-nucleotidase activity during normal pregnancy [<a href="#rid58">58,59</a>]. In contrast, most studies show that serum 5'-nucleotidase does not rise in bone disease [<a href="#rid60">60</a>], and in the few instances in which an increase was observed, it was of low magnitude [<a href="#rid61">61</a>].</p><p>Elevations in serum 5'-nucleotidase are seen in the same types of hepatobiliary diseases associated with an increased serum alkaline phosphatase. Most studies suggest that serum alkaline phosphatase and 5'-nucleotidase are equally valuable in demonstrating biliary obstruction or hepatic infiltrative and space-occupying lesions [<a href="#rid56">56,62</a>]. Although values of the two enzymes are generally correlated, the concentrations may not rise proportionately in individual patients [<a href="#rid55">55,61</a>]. Thus, in selected patients, one enzyme may be elevated and the other normal.</p><p>An increased serum 5'-nucleotidase concentration in a nonpregnant person suggests that a concomitantly increased serum alkaline phosphatase is of hepatic origin. However, because of the occasional dissociation between the two enzymes, a normal serum 5'-nucleotidase does not rule out the liver as the source of an elevated serum alkaline phosphatase. (See  <a class="medical medical_review" href="/d/html/3576.html" rel="external">"Approach to the patient with abnormal liver biochemical and function tests", section on 'Elevated alkaline phosphatase'</a>.)</p><p class="headingAnchor" id="H13"><span class="h1">GAMMA-GLUTAMYL TRANSPEPTIDASE</span></p><p class="headingAnchor" id="H3701649264"><span class="h2">Function and source</span><span class="headingEndMark"> — </span>Gamma-glutamyl transpeptidase (GGT) catalyzes the transfer of the gamma-glutamyl group from gamma-glutamyl peptides such as glutathione to other peptides and to L-amino acids. GGT is present in hepatocytes and biliary epithelial cells and the cell membranes in many tissues, including the kidneys, pancreas, liver, spleen, heart, brain, and seminal vesicles [<a href="#rid63">63</a>]. It is thought to play a role in amino acid transport [<a href="#rid64">64</a>]. </p><p class="headingAnchor" id="H14"><span class="h2">Measurement</span><span class="headingEndMark"> — </span>Enzyme activity is most commonly assayed using gamma-L-glutamyl-r-nitroanilide as a substrate [<a href="#rid65">65</a>]. The liberated product, (chromogen r-nitroaniline) can be measured spectrophotometrically.</p><p class="headingAnchor" id="H15"><span class="h2">Clinical application</span><span class="headingEndMark"> — </span>Aside from its value in conferring liver specificity to an elevated serum alkaline phosphatase level and its possible use in identifying patients with alcohol use disorder, serum GGT offers no advantage over aminotransferases and alkaline phosphatase. Fluorescent probes to detect GGT have been studied as tools for cancer imaging [<a href="#rid66">66</a>].</p><p class="headingAnchor" id="H3419268142"><span class="h3">Normal range</span><span class="headingEndMark"> — </span>GGT is present in the serum of healthy individuals. The normal range is 0 to 30 IU/L (0 to 0.5 mkat/L). Most studies have found values to be comparable in males and females [<a href="#rid67">67,68</a>], although some reports have noted higher values in males [<a href="#rid69">69</a>]. Newborn infants have serum GGT activity six to seven times the upper limit of the adult reference range; levels decline and reach adult levels by five to seven months of age [<a href="#rid70">70</a>]. A gradual increase occurs in girls until age 10 and in boys through adolescence [<a href="#rid71">71</a>]. Serum enzyme activity does not rise during the course of normal pregnancy [<a href="#rid68">68</a>].</p><p class="headingAnchor" id="H3152554308"><span class="h3">Elevated GGT and alkaline phophatase</span><span class="headingEndMark"> — </span>Elevated serum activity is found in diseases of the liver, biliary tract, and pancreas, and reflects the same spectrum of hepatobiliary disease as alkaline phosphatase and 5’-nucleotidase. Serum GGT and alkaline phosphatase correlate reasonably well. There are conflicting data as to whether serum GGT has better sensitivity for hepatobiliary disease than alkaline phosphatase [<a href="#rid68">68,72</a>].</p><p>As with serum 5’-nucleotidase, the major clinical value of serum GGT is in conferring organ specificity to an elevated value for alkaline phosphatase since GGT activity is not increased in patients with bone disease [<a href="#rid68">68</a>]. </p><p class="headingAnchor" id="H4102663151"><span class="h3">Isolated elevation or disproportionate elevation</span><span class="headingEndMark"> — </span>Elevation in serum GGT is not completely specific for hepatobiliary disease. High serum GGT values have been associated with the use of barbiturates or <a class="drug drug_general" data-topicid="9769" href="/d/drug information/9769.html" rel="external">phenytoin</a> [<a href="#rid73">73</a>] or ingestion of large quantities of alcohol [<a href="#rid73">73,74</a>], even when values for other serum enzyme tests and serum bilirubin are normal. In these settings, there is no correlation between the serum GGT and alkaline phosphatase [<a href="#rid63">63</a>]. Rarely, isolated high serum GGT level occurs in families on a genetic basis [<a href="#rid75">75</a>]. </p><p>An isolated elevation in serum GGT or a GGT elevation out of proportion to that of other enzymes (such as the alkaline phosphatase and alanine aminotransferase) may be an indicator of alcohol use or alcohol-associated liver disease [<a href="#rid76">76</a>]. In one prospective study that included 1040 nonselected inpatients, 13 percent had an elevated serum GGT activity; only 32 percent of them had hepatobiliary disease [<a href="#rid77">77</a>]. In the remaining patients, the elevated serum GGT may have been due to alcohol ingestion or medications, which caused a temporary rise in levels but without liver disease.</p><p>The reasons for the elevation in serum GGT with alcohol use are not well understood. Although hepatic microsomal GGT may be induced by alcohol [<a href="#rid78">78</a>], neither elevated serum GGT nor a history or recent alcohol ingestion correlates with hepatic GGT activity in patients with biopsy-proven alcohol-associated liver disease [<a href="#rid79">79,80</a>]. In vitro studies suggest an alternative mechanism: alcohol may cause the leakage of GGT from hepatocytes [<a href="#rid78">78</a>].</p><p class="headingAnchor" id="H16"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Alkaline phosphatase function and sources</strong> – Alkaline phosphatase refers to a group of enzymes that catalyze the hydrolysis of a large number of organic phosphate esters at an alkaline pH optimum. Although alkaline phosphatase is found in many locations throughout the body, its precise function is not fully understood. Alkaline phosphatase activity in serum is derived primarily from three sources: liver (more than 80 percent), bone, and in some patients, the intestinal tract. (See <a class="local">'Sources'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Causes of alkaline phosphatase elevation</strong> – The major value of serum alkaline phosphatase in the diagnosis of liver disorders is in the recognition of cholestatic disease  (<a class="graphic graphic_table graphicRef99099" href="/d/graphic/99099.html" rel="external">table 1</a>). However, an elevation in the alkaline phosphatase concentration is a relatively common finding and does not always indicate the presence of hepatobiliary disease. The degree of elevation does not distinguish intra- from extra-hepatic cholestasis. (See <a class="local">'Clinical interpretation'</a> above and  <a class="medical medical_review" href="/d/html/3576.html" rel="external">"Approach to the patient with abnormal liver biochemical and function tests", section on 'Elevated serum aminotransferases'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Role of 5'-nucleotidase measurement </strong>– Elevations in serum 5'-nucleotidase are seen in the same types of hepatobiliary diseases associated with an increased serum alkaline phosphatase. The value of the 5'-nucleotidase assay is its specificity for hepatobiliary disease. An increased serum 5'-nucleotidase concentration in a nonpregnant person suggests that a concomitantly increased serum alkaline phosphatase is of hepatic origin. However, because of the occasional dissociation between the two enzymes, a normal serum 5'-nucleotidase does not rule out the liver as the source of an elevated serum alkaline phosphatase. (See <a class="local">'5'-Nucleotidase'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cause of gamma-glutamyl transpeptidase elevation</strong> – Elevated serum levels of gamma-glutamyl transpeptidase (GGT) are found in diseases of the liver, biliary tract, and pancreas, and reflect the same spectrum of hepatobiliary disease as alkaline phosphatase and 5'-nucleotidase. Serum GGT and alkaline phosphatase correlate reasonably well. There are conflicting data as to whether serum GGT has better sensitivity for hepatobiliary disease than alkaline phosphatase. The major clinical value of serum GGT is in conferring organ specificity to an elevated value for alkaline phosphatase since GGT activity is not increased in patients with bone disease. However, an elevation in serum GGT is not specific for hepatobiliary disease and may be elevated due to concurrent medications or alcohol use. (See <a class="local">'Gamma-glutamyl transpeptidase'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Newsome PN, Cramb R, Davison SM, et al. Guidelines on the management of abnormal liver blood tests. Gut 2018; 67:6.</a></li><li><a class="nounderline abstract_t">Schreiner AD, Rockey DC. Evaluation of abnormal liver tests in the adult asymptomatic patient. Curr Opin Gastroenterol 2018; 34:272.</a></li><li><a class="nounderline abstract_t">Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Am J Gastroenterol 2017; 112:18.</a></li><li><a class="nounderline abstract_t">Kaplan MM. Alkaline phosphatase. Gastroenterology 1972; 62:452.</a></li><li><a class="nounderline abstract_t">Alvaro D, Benedetti A, Marucci L, et al. The function of alkaline phosphatase in the liver: regulation of intrahepatic biliary epithelium secretory activities in the rat. Hepatology 2000; 32:174.</a></li><li><a class="nounderline abstract_t">Bates JM, Akerlund J, Mittge E, Guillemin K. Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota. Cell Host Microbe 2007; 2:371.</a></li><li><a class="nounderline abstract_t">Fawley J, Gourlay DM. Intestinal alkaline phosphatase: a summary of its role in clinical disease. J Surg Res 2016; 202:225.</a></li><li><a class="nounderline abstract_t">Lallès JP. Recent advances in intestinal alkaline phosphatase, inflammation, and nutrition. Nutr Rev 2019; 77:710.</a></li><li class="breakAll">Sussman HH. Structural analysis of human alkaline phosphatase. In: Human alkaline phosphatase, Stigbrand T, Fisher WH (Eds), Alan R Liss, New York 1984. p.87.</li><li class="breakAll">Lowe D, John S.. StatPearls, StatPearls Publishing, Treasure Island (FL) 2020.</li><li><a class="nounderline abstract_t">Kaplan MM. Alkaline phosphatase. N Engl J Med 1972; 286:200.</a></li><li><a class="nounderline abstract_t">Cho SR, Lim YA, Lee WG. Unusually high alkaline phosphatase due to intestinal isoenzyme in a healthy adult. Clin Chem Lab Med 2005; 43:1274.</a></li><li><a class="nounderline abstract_t">BAMFORD KF, HARRIS H, LUFFMAN JE, et al. SERUM-ALKALINE-PHOSPHATASE AND THE ABO BLOOD-GROUPS. Lancet 1965; 1:530.</a></li><li><a class="nounderline abstract_t">Posen S. Alkaline phosphatase. Ann Intern Med 1967; 67:183.</a></li><li><a class="nounderline abstract_t">Clubb JS, Neale FC, Posen S. The behavior of infused human placental alkaline phosphatase in human subjects. J Lab Clin Med 1965; 66:493.</a></li><li><a class="nounderline abstract_t">Niu X, Ye K, Wang L, et al. A review on emerging principles and strategies for colorimetric and fluorescent detection of alkaline phosphatase activity. Anal Chim Acta 2019; 1086:29.</a></li><li><a class="nounderline abstract_t">Harroun SG, Vallee-Belisle A. Methods to Characterise Enzyme Kinetics with Biological and Medicinal Substrates: The Case of Alkaline Phosphatase. Chemistry Methods 2023; 3:e20220067.</a></li><li><a class="nounderline abstract_t">Brensilver HL, Kaplan MM. Significance of elevated liver alkaline phosphatase in serum. Gastroenterology 1975; 68:1556.</a></li><li><a class="nounderline abstract_t">POSEN S, NEALE FC, CLUBB JS. HEAT INACTIVATION IN THE STUDY OF HUMAN ALKALINE PHOSPHATASES. Ann Intern Med 1965; 62:1234.</a></li><li><a class="nounderline abstract_t">Bahr M, Wilkinson JH. Urea as a selective inhibitor of human tissue alkaline phosphatases. Clin Chim Acta 1967; 17:367.</a></li><li><a class="nounderline abstract_t">ARIAS IM, WOLFSON S, LUCEY JF, MCKAY RJ Jr. TRANSIENT FAMILIAL NEONATAL HYPERBILIRUBINEMIA. J Clin Invest 1965; 44:1442.</a></li><li><a class="nounderline abstract_t">Kuwana T, Sugita O, Yakata M. Reference limits of bone and liver alkaline phosphatase isoenzymes in the serum of healthy subjects according to age and sex as determined by wheat germ lectin affinity electrophoresis. Clin Chim Acta 1988; 173:273.</a></li><li><a class="nounderline abstract_t">HEINO AE, JOKIPII SG. Serum alkaline phosphatase levels in the aged. Ann Med Intern Fenn 1962; 51:105.</a></li><li><a class="nounderline abstract_t">CLARK LC Jr, BECK E. Plasma alkaline phosphatase activity; normative data for growing children. J Pediatr 1950; 36:335.</a></li><li><a class="nounderline abstract_t">Kattwinkel J, Taussig LM, Statland BE, Verter JI. The effects of age on alkaline phosphatase and other serologic liver function tests in normal subjects and patients with cystic fibrosis. J Pediatr 1973; 82:234.</a></li><li><a class="nounderline abstract_t">Salz JL, Daum F, Cohen MI. Serum alkaline phosphatase activity during adolescence. J Pediatr 1973; 82:536.</a></li><li><a class="nounderline abstract_t">Loh TP, Metz MP. Trends and physiology of common serum biochemistries in children aged 0-18 years. Pathology 2015; 47:452.</a></li><li><a class="nounderline abstract_t">Zierk J, Arzideh F, Haeckel R, et al. Pediatric reference intervals for alkaline phosphatase. Clin Chem Lab Med 2017; 55:102.</a></li><li><a class="nounderline abstract_t">Birkett DJ, Done J, Neale FC, Posen S. Serum alkaline phosphatase in pregnancy; an immunological study. Br Med J 1966; 1:1210.</a></li><li><a class="nounderline abstract_t">Stanley Z, Vignes K, Marcum M. Extreme elevations of alkaline phosphatase in pregnancy: A case report. Case Rep Womens Health 2020; 27:e00214.</a></li><li><a class="nounderline abstract_t">Owen MC, Pike LS, George PM, et al. Macro-alkaline phosphatase due to IgG kappa complex: demonstration with polyethylene glycol precipitation and immunofixation. Ann Clin Biochem 2002; 39:523.</a></li><li><a class="nounderline abstract_t">Lallès JP. Intestinal alkaline phosphatase: multiple biological roles in maintenance of intestinal homeostasis and modulation by diet. Nutr Rev 2010; 68:323.</a></li><li><a class="nounderline abstract_t">Siraganian PA, Mulvihill JJ, Mulivor RA, Miller RW. Benign familial hyperphosphatasemia. JAMA 1989; 261:1310.</a></li><li><a class="nounderline abstract_t">Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med 2000; 342:1266.</a></li><li><a class="nounderline abstract_t">Kaplan MM, Righetti A. Induction of rat liver alkaline phosphatase: the mechanism of the serum elevation in bile duct obstruction. J Clin Invest 1970; 49:508.</a></li><li><a class="nounderline abstract_t">Kaplan MM. Serum alkaline phosphatase--another piece is added to the puzzle. Hepatology 1986; 6:526.</a></li><li><a class="nounderline abstract_t">Hatoff DE, Hardison WG. Induced synthesis of alkaline phosphatase by bile acids in rat liver cell culture. Gastroenterology 1979; 77:1062.</a></li><li><a class="nounderline abstract_t">De Broe ME, Borgers M, Wieme RJ. The separation and characterization of liver plasma membrane fragments circulating in the blood of patients with cholestasis. Clin Chim Acta 1975; 59:369.</a></li><li><a class="nounderline abstract_t">Reutemann B, Gordon FD. Evaluation of the Patient with Markedly Abnormal Liver Enzymes. Clin Liver Dis 2023; 27:1.</a></li><li><a class="nounderline abstract_t">Laurent L, Lemaitre C, Minello A, et al. Cholangiopathy in critically ill patients surviving beyond the intensive care period: a multicentre survey in liver units. Aliment Pharmacol Ther 2017; 46:1070.</a></li><li><a class="nounderline abstract_t">Perrillo RP, Griffin R, DeSchryver-Kecskemeti K, et al. Alcoholic liver disease presenting with marked elevation of serum alkaline phosphatase. A combined clinical and pathological study. Am J Dig Dis 1978; 23:1061.</a></li><li><a class="nounderline abstract_t">GUTMAN AB. Serum alkaline phosphatase activity in diseases of the skeletal and hepatobiliary systems. A consideration of the current status. Am J Med 1959; 27:875.</a></li><li><a class="nounderline abstract_t">Boyde TRC, Latner AL. Starch gel electrophoresis of transaminase in human tissue extracts and serum. Biochem J 1961; 82:52.</a></li><li><a class="nounderline abstract_t">Wilson JW. Inherited elevation of alkaline phosphatase activity in the absence of disease. N Engl J Med 1979; 301:983.</a></li><li><a class="nounderline abstract_t">Dalovisio JR, Blonde L, Cortez LM, Pankey GA. Subacute thyroiditis with increased serum alkaline phosphatase. Ann Intern Med 1978; 88:505.</a></li><li><a class="nounderline abstract_t">Fishman WH. Immunologic and biochemical approaches to alkaline phosphatase isoenzyme analysis: the Regan isoenzyme. Ann N Y Acad Sci 1969; 166:745.</a></li><li><a class="nounderline abstract_t">Gremida A, Al-Taee A, Alcorn J, McCarthy D. Hepatic Dysfunction in Renal Cell Carcinoma: Not What You Think? Dig Dis Sci 2017; 62:2298.</a></li><li><a class="nounderline abstract_t">Shaver WA, Bhatt H, Combes B. Low serum alkaline phosphatase activity in Wilson's disease. Hepatology 1986; 6:859.</a></li><li><a class="nounderline abstract_t">Berman DH, Leventhal RI, Gavaler JS, et al. Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure. Gastroenterology 1991; 100:1129.</a></li><li><a class="nounderline abstract_t">Goldberg DM. 5'nucleotidase: recent advances in cell biology, methodology and clinical significance. Digestion 1973; 8:87.</a></li><li><a class="nounderline abstract_t">Righetti A, Kaplan MM. Disparate responses of serum and hepatic alkaline phosphatase and 5' nucleotidase to bile duct obstruction in the rat. Gastroenterology 1972; 62:1034.</a></li><li><a class="nounderline abstract_t">Song CS, Kappas A, Bodansky O. 5'-nucleotidase of plasma membranes of the rat liver: studies on subcellular distribution. Ann N Y Acad Sci 1969; 166:565.</a></li><li><a class="nounderline abstract_t">Schlaeger R, Haux P, Kattermann R. Studies on the mechanism of the increase in serum alkaline phosphatase activity in cholestasis: significance of the hepatic bile acid concentration for the leakage of alkaline phosphatase from rat liver. Enzyme 1982; 28:3.</a></li><li><a class="nounderline abstract_t">Campbell DM. Determination of 5'-nucleotidase in blood serum. Biochem J 1962; 82:348.</a></li><li><a class="nounderline abstract_t">BARDAWILL C, CHANG C. SERUM LACTIC DEHYDROGENASE, LEUCINE AMINOPEPTIDASE AND 5-NUCLEOTIDASE ACTIVITIES: OBSERVATION IN PATIENTS WITH CARCINOMA OF THE PANCREAS AND HEPATOBILIARY DISEASE. Can Med Assoc J 1963; 89:755.</a></li><li><a class="nounderline abstract_t">Hill PG, Sammons HG. An assessment of 5'-nucleotidase as a liver-function test. Q J Med 1967; 36:457.</a></li><li><a class="nounderline abstract_t">Belfield A, Goldberg DM. Normal ranges and diagnostic value of serum 5'nucleotidase and alkaline phosphatase activities in infancy. Arch Dis Child 1971; 46:842.</a></li><li><a class="nounderline abstract_t">Kater RM, Mistilis SP. Obstetric cholestasis and pruritus of pregnancy. Med J Aust 1967; 1:638.</a></li><li><a class="nounderline abstract_t">Seitanidis B, Moss DW. Serum alkaline phosphatase and 5'-nucleotidase levels during normal pregnancy. Clin Chim Acta 1969; 25:183.</a></li><li><a class="nounderline abstract_t">HUNTON DB, BOLLMAN JL, HOFFMAN HN 2nd. The plasma removal on indocyanine green and sulfobromophthalein: effect of dosage and blocking agents. J Clin Invest 1961; 40:1648.</a></li><li><a class="nounderline abstract_t">Eschar J, Rudzki C, Zimmerman HJ. Serum levels of 5'-nucleotidase in disease. Am J Clin Pathol 1967; 47:598.</a></li><li><a class="nounderline abstract_t">KOWLESSAR OD, HAEFFNER LJ, RILEY EM, SLEISENGER MH. Comparative study of serum leucine aminopeptidase, 5-nucleotidase and non-specific alkaline phosphatase in diseases affecting the pancreas, hepatobiliary tree and bone. Am J Med 1961; 31:231.</a></li><li><a class="nounderline abstract_t">Goldberg DM. Structural, functional, and clinical aspects of gamma-glutamyltransferase. CRC Crit Rev Clin Lab Sci 1980; 12:1.</a></li><li><a class="nounderline abstract_t">Meister A. The gamma-glutamyl cycle. Diseases associated with specific enzyme deficiencies. Ann Intern Med 1974; 81:247.</a></li><li><a class="nounderline abstract_t">Szasz G. A kinetic photometric method for serum gamma-glutamyl transpeptidase. Clin Chem 1969; 15:124.</a></li><li><a class="nounderline abstract_t">Saleem M, Hanif M, Rafiq M, et al. γ-Glutamyltranspeptidase (GGT) Sensitive Fluorescence Probes for Cancer Diagnosis; Brief Review. J Fluoresc 2023.</a></li><li><a class="nounderline abstract_t">ARONSEN KF, HANSON A, NOSSLIN B. THE VALUE OF GAMMA-GLUTAMYL TRANSPEPTIDASE IN DIFFERENTIATING VIRAL HEPATITIS FROM OBSTRUCTIVE JAUNDICE. A STATISTICAL COMPARISON WITH ALKALINE PHOSPHATASE. Acta Chir Scand 1965; 130:92.</a></li><li><a class="nounderline abstract_t">Lum G, Gambino SR. Serum gamma-glutamyl transpeptidase activity as an indicator of disease of liver, pancreas, or bone. Clin Chem 1972; 18:358.</a></li><li><a class="nounderline abstract_t">RUTTENBURG AM, GOLDBARG JA, PINEDA EP. SERUM GAMMA-GLUTAMYL TRANSPEPTIDASE ACTIVITY IN HEPATOBILIARY PANCREATIC DISEASE. Gastroenterology 1963; 45:43.</a></li><li><a class="nounderline abstract_t">Cabrera-Abreu JC, Green A. Gamma-glutamyltransferase: value of its measurement in paediatrics. Ann Clin Biochem 2002; 39:22.</a></li><li><a class="nounderline abstract_t">Bussler S, Vogel M, Pietzner D, et al. New pediatric percentiles of liver enzyme serum levels (alanine aminotransferase, aspartate aminotransferase, γ-glutamyltransferase): Effects of age, sex, body mass index, and pubertal stage. Hepatology 2018; 68:1319.</a></li><li><a class="nounderline abstract_t">Betro MG, Oon RC, Edwards JB. Gamma-glutamyl transpeptidase in diseases of the liver and bone. Am J Clin Pathol 1973; 60:672.</a></li><li><a class="nounderline abstract_t">Rosalki SB, Tarlow D, Rau D. Plasma gamma-glutamyl transpeptidase elevation in patients receiving enzyme-inducing drugs. Lancet 1971; 2:376.</a></li><li><a class="nounderline abstract_t">Lamy J, Baglin MC, Ferrant JP, Weill J. [Decrease in serum gamma-glutamyltranspeptidase following abstention from alcohol]. Clin Chim Acta 1974; 56:169.</a></li><li><a class="nounderline abstract_t">De Grandi A, Franzini M, Rosipal Š, et al. Highly Elevated Plasma γ-Glutamyltransferase Elevations: A Trait Caused by γ-Glutamyltransferase 1 Transmembrane Mutations. Hepatology 2020; 71:1124.</a></li><li class="breakAll">Kaplan MM, et al. Biochemical basis for serum enzyme abnormalities in alcoholic liver disease. In: Early identification of alcohol abuse, Research Monograph No. 17, Chang NC, Chan NM (Eds), NIAAA, 1985. p.186.</li><li><a class="nounderline abstract_t">Burrows S, Feldman W, McBride F. Serum gamma-glutamyl transpeptidase. Evaluation in screening of hospitalized patients. Am J Clin Pathol 1975; 64:311.</a></li><li><a class="nounderline abstract_t">Barouki R, Chobert MN, Finidori J, et al. Ethanol effects in a rat hepatoma cell line: induction of gamma-glutamyltransferase. Hepatology 1983; 3:323.</a></li><li><a class="nounderline abstract_t">Ivanov E, Adjarov D, Etarska M, et al. Elevated liver gamma-glutamyl transferase in chronic alcoholics. Enzyme 1980; 25:304.</a></li><li><a class="nounderline abstract_t">Selinger MJ, Matloff DS, Kaplan MM. gamma-Glutamyl transpeptidase activity in liver disease: serum elevation is independent of hepatic GGTP activity. Clin Chim Acta 1982; 125:283.</a></li></ol></div><div id="topicVersionRevision">Topic 3612 Version 28.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29122851" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Guidelines on the management of abnormal liver blood tests.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29697467" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Evaluation of abnormal liver tests in the adult asymptomatic patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27995906" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4551808" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Alkaline phosphatase.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10915721" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The function of alkaline phosphatase in the liver: regulation of intrahepatic biliary epithelium secretory activities in the rat.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18078689" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27083970" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Intestinal alkaline phosphatase: a summary of its role in clinical disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31086953" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Recent advances in intestinal alkaline phosphatase, inflammation, and nutrition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31086953" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Recent advances in intestinal alkaline phosphatase, inflammation, and nutrition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31086953" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Recent advances in intestinal alkaline phosphatase, inflammation, and nutrition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4550137" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Alkaline phosphatase.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16358445" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Unusually high alkaline phosphatase due to intestinal isoenzyme in a healthy adult.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14251523" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : SERUM-ALKALINE-PHOSPHATASE AND THE ABO BLOOD-GROUPS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5339227" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Alkaline phosphatase.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5835974" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : The behavior of infused human placental alkaline phosphatase in human subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31561792" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : A review on emerging principles and strategies for colorimetric and fluorescent detection of alkaline phosphatase activity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Methods to Characterise Enzyme Kinetics with Biological and Medicinal Substrates: The Case of Alkaline Phosphatase</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1093921" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Significance of elevated liver alkaline phosphatase in serum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14295505" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : HEAT INACTIVATION IN THE STUDY OF HUMAN ALKALINE PHOSPHATASES.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6069309" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Urea as a selective inhibitor of human tissue alkaline phosphatases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14332157" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : TRANSIENT FAMILIAL NEONATAL HYPERBILIRUBINEMIA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3383427" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Reference limits of bone and liver alkaline phosphatase isoenzymes in the serum of healthy subjects according to age and sex as determined by wheat germ lectin affinity electrophoresis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13906083" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Serum alkaline phosphatase levels in the aged.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15405413" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Plasma alkaline phosphatase activity; normative data for growing children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4405381" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : The effects of age on alkaline phosphatase and other serologic liver function tests in normal subjects and patients with cystic fibrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4698943" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Serum alkaline phosphatase activity during adolescence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26126034" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Trends and physiology of common serum biochemistries in children aged 0-18 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27505090" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Pediatric reference intervals for alkaline phosphatase.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5933831" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Serum alkaline phosphatase in pregnancy; an immunological study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32461917" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Extreme elevations of alkaline phosphatase in pregnancy: A case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12227863" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Macro-alkaline phosphatase due to IgG kappa complex: demonstration with polyethylene glycol precipitation and immunofixation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20536777" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Intestinal alkaline phosphatase: multiple biological roles in maintenance of intestinal homeostasis and modulation by diet.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2915457" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Benign familial hyperphosphatasemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10781624" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Evaluation of abnormal liver-enzyme results in asymptomatic patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5415676" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Induction of rat liver alkaline phosphatase: the mechanism of the serum elevation in bile duct obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3710439" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Serum alkaline phosphatase--another piece is added to the puzzle.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/488632" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Induced synthesis of alkaline phosphatase by bile acids in rat liver cell culture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1126024" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The separation and characterization of liver plasma membrane fragments circulating in the blood of patients with cholestasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36400459" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Evaluation of the Patient with Markedly Abnormal Liver Enzymes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29023905" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Cholangiopathy in critically ill patients surviving beyond the intensive care period: a multicentre survey in liver units.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/736013" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Alcoholic liver disease presenting with marked elevation of serum alkaline phosphatase. A combined clinical and pathological study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13830463" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Serum alkaline phosphatase activity in diseases of the skeletal and hepatobiliary systems. A consideration of the current status.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Starch gel electrophoresis of transaminase in human tissue extracts and serum</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/492229" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Inherited elevation of alkaline phosphatase activity in the absence of disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25034" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Subacute thyroiditis with increased serum alkaline phosphatase.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5265243" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Immunologic and biochemical approaches to alkaline phosphatase isoenzyme analysis: the Regan isoenzyme.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28785916" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Hepatic Dysfunction in Renal Cell Carcinoma: Not What You Think?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3758940" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Low serum alkaline phosphatase activity in Wilson's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2001814" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4359891" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : 5'nucleotidase: recent advances in cell biology, methodology and clinical significance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5029068" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Disparate responses of serum and hepatic alkaline phosphatase and 5' nucleotidase to bile duct obstruction in the rat.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4314101" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : 5'-nucleotidase of plasma membranes of the rat liver: studies on subcellular distribution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6126356" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Studies on the mechanism of the increase in serum alkaline phosphatase activity in cholestasis: significance of the hepatic bile acid concentration for the leakage of alkaline phosphatase from rat liver.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Determination of 5'-nucleotidase in blood serum</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14060166" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : SERUM LACTIC DEHYDROGENASE, LEUCINE AMINOPEPTIDASE AND 5-NUCLEOTIDASE ACTIVITIES: OBSERVATION IN PATIENTS WITH CARCINOMA OF THE PANCREAS AND HEPATOBILIARY DISEASE.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6077226" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : An assessment of 5'-nucleotidase as a liver-function test.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5129186" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Normal ranges and diagnostic value of serum 5'nucleotidase and alkaline phosphatase activities in infancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6021847" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Obstetric cholestasis and pruritus of pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5797124" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Serum alkaline phosphatase and 5'-nucleotidase levels during normal pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13716909" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : The plasma removal on indocyanine green and sulfobromophthalein: effect of dosage and blocking agents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6022991" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Serum levels of 5'-nucleotidase in disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13753731" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Comparative study of serum leucine aminopeptidase, 5-nucleotidase and non-specific alkaline phosphatase in diseases affecting the pancreas, hepatobiliary tree and bone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6104563" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Structural, functional, and clinical aspects of gamma-glutamyltransferase.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4152527" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : The gamma-glutamyl cycle. Diseases associated with specific enzyme deficiencies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5773262" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : A kinetic photometric method for serum gamma-glutamyl transpeptidase.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37505365" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : γ-Glutamyltranspeptidase (GGT) Sensitive Fluorescence Probes for Cancer Diagnosis; Brief Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14346076" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : THE VALUE OF GAMMA-GLUTAMYL TRANSPEPTIDASE IN DIFFERENTIATING VIRAL HEPATITIS FROM OBSTRUCTIVE JAUNDICE. A STATISTICAL COMPARISON WITH ALKALINE PHOSPHATASE.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5012259" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Serum gamma-glutamyl transpeptidase activity as an indicator of disease of liver, pancreas, or bone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14046310" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : SERUM GAMMA-GLUTAMYL TRANSPEPTIDASE ACTIVITY IN HEPATOBILIARY PANCREATIC DISEASE.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11853185" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Gamma-glutamyltransferase: value of its measurement in paediatrics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28926121" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : New pediatric percentiles of liver enzyme serum levels (alanine aminotransferase, aspartate aminotransferase,γ-glutamyltransferase): Effects of age, sex, body mass index, and pubertal stage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4148049" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Gamma-glutamyl transpeptidase in diseases of the liver and bone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4105075" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Plasma gamma-glutamyl transpeptidase elevation in patients receiving enzyme-inducing drugs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4154814" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : [Decrease in serum gamma-glutamyltranspeptidase following abstention from alcohol].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31520399" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Highly Elevated Plasmaγ-Glutamyltransferase Elevations: A Trait Caused byγ-Glutamyltransferase 1 Transmembrane Mutations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31520399" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Highly Elevated Plasmaγ-Glutamyltransferase Elevations: A Trait Caused byγ-Glutamyltransferase 1 Transmembrane Mutations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/240269" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Serum gamma-glutamyl transpeptidase. Evaluation in screening of hospitalized patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6132864" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Ethanol effects in a rat hepatoma cell line: induction of gamma-glutamyltransferase.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6108853" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Elevated liver gamma-glutamyl transferase in chronic alcoholics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6129080" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : gamma-Glutamyl transpeptidase activity in liver disease: serum elevation is independent of hepatic GGTP activity.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
